Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Mice with different susceptibility to tick-borne encephalitis virus infection show selective neutralizing antibody response and inflammatory reaction in the central nervous system

M. Palus, J. Vojtíšková, J. Salát, J. Kopecký, L. Grubhoffer, M. Lipoldová, P. Demant, D. Růžek,

. 2013 ; 10 (-) : 77.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14040683

BACKGROUND: The clinical course of tick-borne encephalitis (TBE), a disease caused by TBE virus, ranges from asymptomatic or mild influenza-like infection to severe debilitating encephalitis or encephalomyelitis. Despite the medical importance of this disease, some crucial steps in the development of encephalitis remain poorly understood. In particular, the basis of the disease severity is largely unknown. METHODS: TBE virus growth, neutralizing antibody response, key cytokine and chemokine mRNA production and changes in mRNA levels of cell surface markers of immunocompetent cells in brain were measured in mice with different susceptibilities to TBE virus infection. RESULTS: An animal model of TBE based on BALB/c-c-STS/A (CcS/Dem) recombinant congenic mouse strains showing different severities of the infection in relation to the host genetic background was developed. After subcutaneous inoculation of TBE virus, BALB/c mice showed medium susceptibility to the infection, STS mice were resistant, and CcS-11 mice were highly susceptible. The resistant STS mice showed lower and delayed viremia, lower virus production in the brain and low cytokine/chemokine mRNA production, but had a strong neutralizing antibody response. The most sensitive strain (CcS-11) failed in production of neutralizing antibodies, but exhibited strong cytokine/chemokine mRNA production in the brain. After intracerebral inoculation, all mouse strains were sensitive to the infection and had similar virus production in the brain, but STS mice survived significantly longer than CcS-11 mice. These two strains also differed in the expression of key cytokines/chemokines, particularly interferon gamma-induced protein 10 (IP-10/CXCL10) and monocyte chemotactic protein-1 (MCP-1/CCL2) in the brain. CONCLUSIONS: Our data indicate that the genetic control is an important factor influencing the clinical course of TBE. High neutralizing antibody response might be crucial for preventing host fatality, but high expression of various cytokines/chemokines during TBE can mediate immunopathology and be associated with more severe course of the infection and increased fatality.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14040683
003      
CZ-PrNML
005      
20230808121839.0
007      
ta
008      
140107s2013 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/1742-2094-10-77 $2 doi
035    __
$a (PubMed)23805778
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Palus, Martin
245    10
$a Mice with different susceptibility to tick-borne encephalitis virus infection show selective neutralizing antibody response and inflammatory reaction in the central nervous system / $c M. Palus, J. Vojtíšková, J. Salát, J. Kopecký, L. Grubhoffer, M. Lipoldová, P. Demant, D. Růžek,
520    9_
$a BACKGROUND: The clinical course of tick-borne encephalitis (TBE), a disease caused by TBE virus, ranges from asymptomatic or mild influenza-like infection to severe debilitating encephalitis or encephalomyelitis. Despite the medical importance of this disease, some crucial steps in the development of encephalitis remain poorly understood. In particular, the basis of the disease severity is largely unknown. METHODS: TBE virus growth, neutralizing antibody response, key cytokine and chemokine mRNA production and changes in mRNA levels of cell surface markers of immunocompetent cells in brain were measured in mice with different susceptibilities to TBE virus infection. RESULTS: An animal model of TBE based on BALB/c-c-STS/A (CcS/Dem) recombinant congenic mouse strains showing different severities of the infection in relation to the host genetic background was developed. After subcutaneous inoculation of TBE virus, BALB/c mice showed medium susceptibility to the infection, STS mice were resistant, and CcS-11 mice were highly susceptible. The resistant STS mice showed lower and delayed viremia, lower virus production in the brain and low cytokine/chemokine mRNA production, but had a strong neutralizing antibody response. The most sensitive strain (CcS-11) failed in production of neutralizing antibodies, but exhibited strong cytokine/chemokine mRNA production in the brain. After intracerebral inoculation, all mouse strains were sensitive to the infection and had similar virus production in the brain, but STS mice survived significantly longer than CcS-11 mice. These two strains also differed in the expression of key cytokines/chemokines, particularly interferon gamma-induced protein 10 (IP-10/CXCL10) and monocyte chemotactic protein-1 (MCP-1/CCL2) in the brain. CONCLUSIONS: Our data indicate that the genetic control is an important factor influencing the clinical course of TBE. High neutralizing antibody response might be crucial for preventing host fatality, but high expression of various cytokines/chemokines during TBE can mediate immunopathology and be associated with more severe course of the infection and increased fatality.
650    _2
$a zvířata $7 D000818
650    _2
$a neutralizující protilátky $x biosyntéza $7 D057134
650    _2
$a protilátky virové $x biosyntéza $x genetika $7 D000914
650    _2
$a mozek - chemie $x fyziologie $7 D001923
650    _2
$a centrální nervový systém $x patologie $7 D002490
650    _2
$a chemokiny $x biosyntéza $7 D018925
650    _2
$a cytokiny $x biosyntéza $7 D016207
650    _2
$a odolnost vůči nemocem $7 D060467
650    _2
$a náchylnost k nemoci $7 D004198
650    12
$a viry klíšťové encefalitidy $7 D004669
650    _2
$a klíšťová encefalitida $x imunologie $x patologie $7 D004675
650    _2
$a genotyp $7 D005838
650    _2
$a buněčná imunita $x imunologie $7 D007111
650    _2
$a zánět $x patologie $7 D007249
650    _2
$a membránové proteiny $x biosyntéza $7 D008565
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední BALB C $7 D008807
650    _2
$a messenger RNA $x biosyntéza $x genetika $7 D012333
650    _2
$a kvantitativní polymerázová řetězová reakce $7 D060888
650    _2
$a virová nálož $7 D019562
650    _2
$a plakové testy $7 D010948
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vojtíšková, Jarmila $u -
700    1_
$a Salát, Jiří $u -
700    1_
$a Kopecký, Jan $u -
700    1_
$a Grubhoffer, Libor $u -
700    1_
$a Lipoldová, Marie $u -
700    1_
$a Demant, Peter $u -
700    1_
$a Růžek, Daniel, $d 1981- $7 stk2008441707
773    0_
$w MED00163330 $t Journal of neuroinflammation $x 1742-2094 $g Roč. 10, č. - (2013), s. 77
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23805778 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140107 $b ABA008
991    __
$a 20230808121836 $b ABA008
999    __
$a ok $b bmc $g 1005079 $s 839195
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 10 $c - $d 77 $i 1742-2094 $m Journal of neuroinflammation $n J Neuroinflammation $x MED00163330
LZP    __
$a Pubmed-20140107

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...